Method for prognosing cancer and the proteins involved
US6780984B2 · kind B2 · utility
25Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 2001 |
| Grant date | Aug 24, 2004 |
| Priority date | — |
| Expiry date | Jul 16, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses methods of distinguishing aggressive forms of prostate cancer from non-aggressive forms. In particular, two proteins that are specifically down-regulated in aggressive prostate cancer cells have been identified. One of the proteins is a novel transcription factor that is specifically involved in the apoptosis of cancer cells. The nucleic acid and amino acid sequences of the novel transcription factor is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.